Soliris®

AstraZeneca’s Soliris® Is Approved in Malaysia for Treatment of Rare Neurological Autoimmune Diseases and Severe Blood Disorders

AstraZeneca, a global, science-led biopharmaceutical company, has made available its treatment, Soliris®, in Malaysia as part of its ongoing commitment… Read More

3 hours ago

This website uses cookies.